ReproCELL Licensing
ReproCELL licensed commercialization right on human iPS cell derived hepatocytes. -Expected launch in Q2 2012- >> PR Newswire
June 15-18
ISSCR 9th Annual Meeting
ReproCELL will have booth #829 to promote iPS/ES cell culture reagents as well as iPSC-derived cardiomyocytes and neurons.
Metro Toronto Convention Centre, Toronto, Ontario, Canada
